SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-055074
Filing Date
2024-05-08
Accepted
2024-05-08 07:44:20
Documents
5
Period of Report
2024-05-08

Document Format Files

Seq Description Document Type Size
1 6-K achl-2023-6-k-q12024.htm 6-K 35734
2 EX-99.1 achl-ex99_1.htm EX-99.1 131309
3 EX-99.2 achl-ex99_2.htm EX-99.2 685470
4 EX-99.3 achl-ex99_3.htm EX-99.3 207215
5 GRAPHIC img60901631_0.jpg GRAPHIC 109156
  Complete submission text file 0000950170-24-055074.txt   1211306
Mailing Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW 44 (0)20 8154 4600
Achilles Therapeutics plc (Filer) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40299 | Film No.: 24924274
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)